Panel advances bill to ban 'white‑bagging' and 'brown‑bagging' in specialty drug delivery

A Senate committee on an administrative agenda reported House Bill 17 after a presentation from Senator Boyd, who said the bill would prohibit so‑called 'white bagging' and 'brown bagging' practices by insurers and pharmacy benefit managers.

Senator Boyd said the measures can impede timely care. "White bagging... can delay the patient's treatment, anywhere from 10 to 14 days oftentimes," he said, and described brown bagging as requiring patients to procure drugs from a specialty pharmacy and bring them to a clinic, raising concerns about temperature control and provider oversight.

Supporters told the committee the bill would align Mississippi with neighboring states and argued it protects patient access and treatment quality. Senator Boyd said the measure would "line us up with our states that are right next to us with Louisiana and Arkansas." The bill's sponsor offered to answer detailed questions but limited the presentation, saying the committee had reviewed it previously.

Central Frasier moved 'title sufficient to pass,' and the committee approved the motion by voice vote. The chair said the bill "will be reported." No roll‑call tally was provided in the transcript.

The bill's discussion in committee focused on access and clinical concerns rather than costs or implementation mechanics. The transcript records no technical rulemaking language or a specific enforcement timeline; those details would be developed in later stages if the bill advances.

The committee took no recorded amendments on the floor during the session and moved the bill forward to the next step in the process.